2022
DOI: 10.1038/s41537-022-00265-5
|View full text |Cite
|
Sign up to set email alerts
|

Impaired verbal memory function is related to anterior cingulate glutamate levels in schizophrenia: findings from the STRATA study

Abstract: Impaired cognition is associated with lower quality of life and poor outcomes in schizophrenia. Brain glutamate may contribute to both clinical outcomes and cognition, but these relationships are not well-understood. We studied a multicentre cohort of 85 participants with non-affective psychosis using proton magnetic resonance spectroscopy. Glutamate neurometabolites were measured in the anterior cingulate cortex (ACC). Cognition was assessed using the Brief Assessment for Cognition in Schizophrenia (BACS). Pa… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 79 publications
0
4
0
Order By: Relevance
“…Meta-analytic studies have identified lower glutamate levels in voxels, including the ACC of patients with schizophrenia compared with healthy volunteers ( Marsman et al, 2013 ; Merritt et al, 2023 ). Moreover, studies have found that lower glutamate metabolite levels in the ACC of patients with schizophrenia are correlated to poorer cognitive task performance ( Ohrmann et al, 2008 ; Bojesen et al, 2021 ; Coughlin et al, 2021 ; Griffiths et al, 2022 ). The findings that we report, together with existing evidence of lower ACC glutamate levels being associated with impaired cognition, suggest that H3R antagonism in patients with schizophrenia may improve cognitive impairment, which is a feature of the disorder, by increasing glutamate transmission.…”
Section: Discussionmentioning
confidence: 99%
“…Meta-analytic studies have identified lower glutamate levels in voxels, including the ACC of patients with schizophrenia compared with healthy volunteers ( Marsman et al, 2013 ; Merritt et al, 2023 ). Moreover, studies have found that lower glutamate metabolite levels in the ACC of patients with schizophrenia are correlated to poorer cognitive task performance ( Ohrmann et al, 2008 ; Bojesen et al, 2021 ; Coughlin et al, 2021 ; Griffiths et al, 2022 ). The findings that we report, together with existing evidence of lower ACC glutamate levels being associated with impaired cognition, suggest that H3R antagonism in patients with schizophrenia may improve cognitive impairment, which is a feature of the disorder, by increasing glutamate transmission.…”
Section: Discussionmentioning
confidence: 99%
“…Nevertheless, there was no evidence that IL-6 increases directly mediated the late phase decrease in ACC glutamate (Figure 3D). Indeed, low ACC glutamate was recently associated with polygenic risk for reduced NMDA receptor function shared with treatment resistance albeit in a younger cohort than the Established group [59].…”
Section: Discussionmentioning
confidence: 99%
“…High glutamate in ACC has been now consistently linked with the status of being a non-responder (5860) or being treatment-resistant, both indicating persistent high levels of positive symptoms. The lack of Glu-symptom correlation may reflect MRS glutamate measures being an indirect measure for NMDA receptor dysfunction(61), but not the secondary disinhibition that is likely mediated via interneuron downregulation. In fact, dynamic causal models (DCM) of brain connectivity that recovers parameters reflecting interneuron-mediated inhibitory tone, indicates that higher MRS glutamate in dACC relates to higher inhibitory interneuron tone, not disinhibition(62).…”
Section: Discussionmentioning
confidence: 99%